Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03696797 · ClinicalTrials.gov registry record · NA
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT03696797 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 132 participants.
The verdict
NCT03696797, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
This is a treatment study to determine if reducing the body's iron stores by blood donation will improve diabetes control and other problems associated with diabetes such as fatty liver disease.
Interventions
- PROCEDURE Blood Donation
- PROCEDURE Sham Blood Donation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2019-05-03 |
| Est. Completion | 2025-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03696797
The ClinicalTrials.gov registry entry for NCT03696797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Donation is the first listed.
NCT03696797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03696797 about?
NCT03696797 is a clinical study titled "Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease". This is a treatment study to determine if reducing the body's iron stores by blood donation will improve diabetes control and other problems associated with diabetes such as fatty liver disease.
What is the current status of trial NCT03696797?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2019-05-03. Estimated completion is 2025-01-03.
What interventions are being tested in trial NCT03696797?
The interventions under investigation include: Blood Donation (PROCEDURE), Sham Blood Donation (PROCEDURE).
Who is sponsoring clinical trial NCT03696797?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.